From: Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong
OR | 95% C.I | p-value | aOR | 95% C.I | p-value | |
---|---|---|---|---|---|---|
≥ 3 points decrease in ACT score | 4.174 | 2.116–8.234 | < 0.001* | 3.105 | 1.385–6.959 | 0.006* |
Escalation of asthma maintenance therapy by at least 1 GINA step | 3.798 | 1.349–10.694 | 0.012* | 4.733 | 1.151–19.467 | 0.031* |
Asthma uncontrolled | 2.774 | 1.214–6.338 | 0.016* | 5.509 | 1.061–28.600 | 0.042* |
Asthma from controlled to uncontrolled | 8.209 | 3.018–22.233 | < 0.001* | 7.532 | 2.268–25.013 | < 0.001* |
Medical attendance for asthmatic exacerbation | 1.083 | 0.471–2.492 | 0.851 | – | – | – |
Oral corticosteroid prescribed for exacerbation | 1.298 | 0.466–3.618 | 0.618 | – | – | – |